1 of 1
Story summary
- U.S. President Donald Trump nominated Dr. Heidi Overton as FDA commissioner.
- Overton, a White House deputy domestic policy director, celebrated the overturn of Roe v. Wade.
- She authored an America First Policy Institute brief that spread disinformation about medication-abortion safety.
- Pro-life group Americans United for Life expects Overton to tighten mifepristone rules.
- Senate hearing on Overton’s nomination is slated for Sept. 14 after the recess.
